Menu Back toSession-0305-Clinical-Science-I-Development-Strategy
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
The 7th DIA China Annual Meeting
Session 0305 Clinical Science - I - Development Strategy
- Chief Medical Officer, Infectious Diseases
- Everest Medicines, China
Holistic Approaches to Biopharmaceutical Product Development
Theo J Hoofwijk
- Executive Director, Global Strategic Drug Development
- Center for Integrated Drug Development, Quintiles, Netherlands, China
Clinical Development Plan Considerations for China Local Innovations (EN&CN)
Ning Xu, MD, MBA
- Executive Vice President, Head of Clinical Development and Regulatory Affairs
- Zai Lab, China